Goodwill E-Health Info Co., Ltd. (SHA:688246)
China · Delayed Price · Currency is CNY 28.31
+1.25 (4.62%)
Jan 23, 2026, 3:00 PM CST
Goodwill E-Health Info Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 | 2018 - 2020 |
| 446.05 | 591.94 | 695.18 | 716.95 | 651.94 | 531.84 | Upgrade | |
Revenue Growth (YoY) | -29.56% | -14.85% | -3.04% | 9.97% | 22.58% | 19.85% | Upgrade |
Cost of Revenue | 441.5 | 429.06 | 355.99 | 355.96 | 326.18 | 269.95 | Upgrade |
Gross Profit | 4.55 | 162.89 | 339.19 | 360.99 | 325.76 | 261.89 | Upgrade |
Selling, General & Admin | 168.15 | 184.89 | 195.93 | 191.33 | 177.72 | 152.74 | Upgrade |
Research & Development | 104.39 | 136.21 | 137.39 | 147.02 | 117.04 | 86.07 | Upgrade |
Other Operating Expenses | -11.2 | -14.78 | -13.35 | -8.74 | -17.31 | -17.72 | Upgrade |
Operating Expenses | 337.11 | 376.25 | 354.35 | 362.07 | 305.32 | 247.9 | Upgrade |
Operating Income | -332.56 | -213.37 | -15.17 | -1.08 | 20.44 | 13.98 | Upgrade |
Interest Expense | -10.45 | -9.82 | -2.74 | -1.68 | -6.11 | -1.79 | Upgrade |
Interest & Investment Income | 1.36 | 3.86 | 10.08 | 17.38 | 1.66 | 0.63 | Upgrade |
Currency Exchange Gain (Loss) | 0 | 0 | 0 | 0 | -0.02 | 0.01 | Upgrade |
Other Non Operating Income (Expenses) | -2.02 | -2.89 | -1.49 | -1.35 | -2.55 | -1.1 | Upgrade |
EBT Excluding Unusual Items | -343.68 | -222.22 | -9.32 | 13.27 | 13.44 | 11.74 | Upgrade |
Gain (Loss) on Sale of Investments | -11.27 | -12.85 | - | - | -0.04 | -0.16 | Upgrade |
Gain (Loss) on Sale of Assets | -0.03 | 0.05 | -0 | -0 | 0.04 | 0.11 | Upgrade |
Asset Writedown | -0.83 | - | -0.07 | -0.08 | -0.06 | -1.08 | Upgrade |
Other Unusual Items | 5.18 | 5.09 | 4.73 | 14.18 | 13.05 | - | Upgrade |
Pretax Income | -350.63 | -229.92 | -4.67 | 27.37 | 26.43 | 10.61 | Upgrade |
Income Tax Expense | 85.21 | 68.29 | -14.74 | -13.36 | -6.46 | -2.1 | Upgrade |
Earnings From Continuing Operations | -435.84 | -298.22 | 10.07 | 40.73 | 32.89 | 12.71 | Upgrade |
Minority Interest in Earnings | 47.42 | 42.1 | 22.22 | 27.29 | 16.72 | 8.56 | Upgrade |
Net Income | -388.43 | -256.12 | 32.28 | 68.02 | 49.61 | 21.27 | Upgrade |
Net Income to Common | -388.43 | -256.12 | 32.28 | 68.02 | 49.61 | 21.27 | Upgrade |
Net Income Growth | - | - | -52.54% | 37.13% | 133.27% | 521.54% | Upgrade |
Shares Outstanding (Basic) | 138 | 138 | 140 | 139 | 103 | 101 | Upgrade |
Shares Outstanding (Diluted) | 138 | 138 | 140 | 139 | 103 | 101 | Upgrade |
Shares Change (YoY) | -1.16% | -1.90% | 1.11% | 34.33% | 2.06% | -11.21% | Upgrade |
EPS (Basic) | -2.82 | -1.86 | 0.23 | 0.49 | 0.48 | 0.21 | Upgrade |
EPS (Diluted) | -2.82 | -1.86 | 0.23 | 0.49 | 0.48 | 0.21 | Upgrade |
EPS Growth | - | - | -53.06% | 2.08% | 128.57% | 600.00% | Upgrade |
Free Cash Flow | -183.02 | -203.46 | -208.6 | -329.16 | -214.03 | -72.64 | Upgrade |
Free Cash Flow Per Share | -1.33 | -1.48 | -1.49 | -2.37 | -2.07 | -0.72 | Upgrade |
Gross Margin | 1.02% | 27.52% | 48.79% | 50.35% | 49.97% | 49.24% | Upgrade |
Operating Margin | -74.56% | -36.05% | -2.18% | -0.15% | 3.14% | 2.63% | Upgrade |
Profit Margin | -87.08% | -43.27% | 4.64% | 9.49% | 7.61% | 4.00% | Upgrade |
Free Cash Flow Margin | -41.03% | -34.37% | -30.01% | -45.91% | -32.83% | -13.66% | Upgrade |
EBITDA | -332.95 | -210.17 | -7.19 | 2.55 | 23.9 | 17.46 | Upgrade |
EBITDA Margin | -74.64% | -35.50% | -1.03% | 0.36% | 3.67% | 3.28% | Upgrade |
D&A For EBITDA | -0.38 | 3.2 | 7.98 | 3.64 | 3.46 | 3.47 | Upgrade |
EBIT | -332.56 | -213.37 | -15.17 | -1.08 | 20.44 | 13.98 | Upgrade |
EBIT Margin | -74.56% | -36.05% | -2.18% | -0.15% | 3.14% | 2.63% | Upgrade |
Revenue as Reported | 446.05 | 591.94 | 695.18 | 716.95 | 651.94 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.